Ideaya Biosciences Share Price Today
(NASDAQ: IDYA)

Name: Ideaya Biosciences Share Price Today (NASDAQ: IDYA) - Ideaya Biosciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Ideaya Biosciences share price is $24.35 & ₹2,109.68 as on 1 Feb 2025, 2.30 'hrs' IST

$24.35

▲

0.47

(1.97%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Ideaya Biosciences share price in Dollar and Rupees. Guide to invest in Ideaya Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ideaya Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Ideaya Biosciences share price movements

Today's Low: $23.93
Today's High: $24.94
$24.35
1.72%
Downside
Day's Volatility :4.03%
Upside
2.35%
52 Weeks Low: $22.10
52 Weeks High: $47.74
$24.35
9.24%
Downside
52 Weeks Volatility :53.7%
Upside
48.99%

Ideaya Biosciences (IDYA) Returns

Period	Ideaya Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.83%	-0.6%	0.0%
6 Months	-34.17%	-2.8%	0.0%
1 Year	-45.07%	3.3%	0.0%
3 Years	50.31%	11.6%	-13.7%

Ideaya Biosciences (IDYA) Key Statistics

in dollars & INR

Previous Close	$23.88
Open	$23.89
Today's High	$24.935
Today's Low	$23.93
Market Capitalization	$2.1B
Today's Volume	$953.0K
52 Week High	$47.735
52 Week Low	$22.1
Revenue TTM	$3.9M
EBITDA	$-222.3M
Earnings Per Share (EPS)	$-2.33
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-21.1%

How to invest in Ideaya Biosciences Stock (IDYA) from India?

It is very easy for Indian residents to invest directly in Ideaya Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ideaya Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ideaya Biosciences or IDYA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ideaya Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ideaya Biosciences shares which would translate to 0.036 fractional shares of Ideaya Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ideaya Biosciences, in just a few clicks!

Returns in Ideaya Biosciences (IDYA) for Indian investors in Rupees

The Ideaya Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Ideaya Biosciences investment value today

Current value as on today

₹59,488

Returns

₹40,512

(-40.51%)

Returns from Ideaya Biosciences Stock

₹45,071 (-45.07%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Ideaya Biosciences (IDYA)

-39%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Ideaya Biosciences Stock from India on INDmoney has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ideaya Biosciences

FMR Inc
14.62%
BlackRock Inc
8.89%
Federated Hermes Inc
6.03%
HHG PLC
5.97%
Vanguard Group Inc
5.55%
T. Rowe Price Associates, Inc.
4.65%

Analyst Recommendation on Ideaya Biosciences

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Ideaya Biosciences(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ideaya Biosciences Stock (IDYA)

What analysts predicted

Upside of 128.81%

Target:

$55.71

Current:

$24.35

Insights on Ideaya Biosciences Stock (Ticker Symbol: IDYA)

Price Movement
In the last 7 days, IDYA stock has moved up by 3.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 8.03M → 3.92M (in $), with an average decrease of 51.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -52.77M → -51.82M (in $), with an average increase of 1.8% per quarter
IDYA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 55.1% return, outperforming this stock by 100.4%
IDYA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 87.2% return, outperforming this stock by 44.8%
Price to Sales
ForIDYA every $1 of sales, investors are willing to pay $477.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.

Ideaya Biosciences Technicals Summary

Sell

Neutral

Buy

Ideaya Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ideaya Biosciences (IDYA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ideaya Biosciences Inc	-3.22%	-34.17%	-45.07%	50.31%	168.76%
Biontech Se	7.35%	57.95%	33.59%	-31.3%	308.89%
Regeneron Pharmaceuticals, Inc.	-5.9%	-37.18%	-28.8%	8.05%	97.29%
Vertex Pharmaceuticals Incorporated	13.78%	-3.19%	8.71%	82.07%	100.29%
Alnylam Pharmaceuticals, Inc.	16.13%	2.38%	56.77%	86.78%	136.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ideaya Biosciences Inc	NA	NA	NA	-2.4	-0.21	-0.16	NA	13.67
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.89	16.89	1.06	44.96	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.15	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ideaya Biosciences Inc	Buy	$2.1B	168.76%	NA	0.0%
Biontech Se	Buy	$29.0B	308.89%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.1B	97.29%	16.89	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$112.9B	100.29%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.7B	136.62%	NA	-15.86%

Ideaya Biosciences Dividend announcements

Ideaya Biosciences Earnings
Ideaya Biosciences’s price-to-earnings ratio stands at None
Read More

About Ideaya Biosciences

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 1/2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung, bladder, gastric, and esophageal cancers; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; GSK101, a Pol Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other homologous recombination, and HRD mutations; and Werner Helicase inhibitors for tumors with high microsatellite instability. It offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Novartis International Pharmaceuticals Ltd., Amgen Inc., Gilead Sciences, Inc., Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Organization	Ideaya Biosciences
Employees	124
CEO	Mr. Yujiro S. Hata
Industry	Biotechnology

Management People of Ideaya Biosciences

Name	Title
Mr. Yujiro S. Hata	President, CEO & Director
Mr. Andres Ruiz Briseno CPA	Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations
Dr. Michael A. White Ph.D.	Chief Scientific Officer
Dr. Darrin M. Beaupre M.D., Ph.D.	Chief Medical Officer
Dr. Paul A. Barsanti Ph.D.	Chief Technology Officer
Mr. Douglas B. Snyder	Senior VP & General Counsel
Ms. Francine Zelaya	Vice President & Head of Human Resources
Mr. Mick O'Quigley	Chief of Staff & Clinical Development
Mr. Daniel A. Simon	Chief Business Officer
Mr. Stuart Dorman	Chief Commercial Officer

Important FAQs about investing in IDYA Stock from India :

What is Ideaya Biosciences share price today?

Ideaya Biosciences share price today stands at $24.35, Open: $23.89 ; Previous Close: $23.88 ; High: $24.94 ; Low: $23.93 ; 52 Week High: $47.74 ; 52 Week Low: $22.10.

The stock opens at $23.89, after a previous close of $23.88. The stock reached a daily high of $24.94 and a low of $23.93, with a 52-week high of $47.74 and a 52-week low of $22.10.

Can Indians buy Ideaya Biosciences shares?

Yes, Indians can invest in the Ideaya Biosciences (IDYA) from India.

With INDmoney, you can buy Ideaya Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ideaya Biosciences at zero transaction cost.

How can I buy Ideaya Biosciences shares from India?

It is very easy to buy Ideaya Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ideaya Biosciences (IDYA) be purchased?

Yes, you can buy fractional shares of Ideaya Biosciences with INDmoney app.

What are the documents required to start investing in Ideaya Biosciences stocks?

To start investing in Ideaya Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.